T. Rowe Price Associates, Inc. (I.. recently announced the acquisition of new stake in Constellium SE (NYSE:CSTM). The institutional investor has increased its shareholding in the Basic Materials company by 7.15% to 12.21 million shares with purchase of 0.82 million shares. This fresh investment now brings its stake to 8.85% valued currently at $97.81 million. In addition, Boussard & Gavaudan Investment Ma.. raised its holdings by 1.64 million to 6.36 million shares.

With over 1.06 million Constellium SE (CSTM) shares trading Tuesday and a closing price of $8.32 on the day, the dollar volume was approximately $8.8 million. The shares have shown a positive weekly performance of 2.21% and its price on 09/01/20 gained nearly 3.87%. Currently, there are 137.90M common shares owned by the public and among those 136.34M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 6 analysts who have offered their price forecasts for CSTM have a consensus price objective of $11.00. The analysts have set the share’s price value over the next 12 months at a high of $16.13 and a low of $8.49 should the stock experience a downside. Incidentally, analysts’ outlook for the Constellium SE stock is 2.20 for the next 12 months. The average price target is 36.15% above its last price level and an upside to the estimated low will see the stock gain 2.0% over that period. But an upside of 48.42% will see the stock hit the forecast high price target while mean target price for the stock is $10.35.

Shares of Constellium SE (NYSE: CSTM) opened at $7.95, down -$0.06 from a prior closing price of $8.01. However, the script later closed the day at $8.32, up 3.87%. The company’s stock has a 5-day price change of 2.21% and -12.88% over the past three months. CSTM shares are trading -37.91% year to date (YTD), with the 12-month market performance down to -28.52% lower. It has a 12-month low price of $3.90 and touched a high of $15.10 over the same period. Currently, 1.06 million shares have been traded, compared to an average intraday trading volume of 1.19 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.76%, 1.02%, and -13.88% respectively.

Institutional ownership of Constellium SE (NYSE: CSTM) shares accounts for 87.30% of the company’s 137.90M shares outstanding. Mutual fund holders own 26.24%, while other institutional holders and individual stakeholders account for 49.43% and — respectively.

It has a market capitalization of $1.13B and a beta (3y monthly) value of 2.12. The earnings-per-share (ttm) stands at -$0.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.27% over the week and 4.51% over the month.

Analysts forecast that Constellium SE (CSTM) will achieve an EPS of -$0.03 for the current quarter, -$0.03 for the next quarter and $0.83 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.26 while analysts give the company a high EPS estimate of $0.08. Comparatively, EPS for the current quarter was $0 a year ago. Earnings per share for the fiscal year are expected to decrease by -69.60%, and 814.30% over the next financial year. EPS should grow at an annualized rate of 49.41% over the next five years, compared to -3.10% over the past 5-year period.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 6 brokerage firm advisors rate Constellium SE (CSTM) as a “Moderate Buy” at a consensus score of 2.20. Specifically, 5 Wall Street analysts polled rate the stock as a buy, while 1 of the 6 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the CSTM, a number of firms have released research notes about the stock. The Benchmark Company stated their Buy rating for the stock in a research note on January 16, 2020, with the firm’s price target at $17. Northland Capital coverage for the Constellium SE (CSTM) stock in a research note released on January 13, 2020 offered a Outperform rating with a price target of $19. Societe Generale was of a view on October 30, 2018 that the stock is Buy, while Jefferies gave the stock Buy rating on July 16, 2018, issuing a price target of $14. Seaport Global Securities on their part issued Buy rating on April 27, 2018.